We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+3.07%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$464M
AUM Growth
+$254K
Cap. Flow
-$11.5M
Cap. Flow %
-2.47%
Top 10 Hldgs %
46.69%
Holding
69
New
–
Increased
32
Reduced
23
Closed
5

Top Buys

1
GNTX icon
Gentex
GNTX
+$5.51M
2
WBA
Walgreens Boots Alliance
WBA
+$4.42M
3
PEP icon
PepsiCo
PEP
+$2.84M
4
WFC icon
Wells Fargo
WFC
+$1.71M
5
COL
Rockwell Collins
COL
+$1.67M

Top Sells

1
MDT icon
Medtronic
MDT
+$14.9M
2
VZ icon
Verizon
VZ
+$9.42M
3
BHI
Baker Hughes
BHI
+$3.91M
4
BAX icon
Baxter International
BAX
+$3.16M
5
SYT
Syngenta Ag
SYT
+$2.5M

Sector Composition

1 Healthcare 29.4%
2 Technology 18.16%
3 Industrials 14.55%
4 Financials 12.21%
5 Consumer Staples 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHRW icon
26
C.H. Robinson
CHRW
$24.3B
$5.79M 1.25%
84,239
+17,353
+26% +$1.23M
SABR icon
27
Sabre
SABR
$684M
$5.69M 1.23%
261,238
+11,429
+5% +$260K
MRK icon
28
Merck
MRK
$315B
$5.08M 1.1%
83,105
-654
-0.8% -$39.8K
NVO
29
Novo Nordisk
NVO
$222B
$4.91M 1.06%
229,062
-5,722
-2% -$115K
HSY icon
30
Hershey
HSY
$34.7B
$4.85M 1.05%
45,205
+7,458
+20% +$823K
UNH icon
31
UnitedHealth
UNH
$395B
$4.23M 0.91%
22,826
+6,414
+39% +$1.12M
KO icon
32
Coca-Cola
KO
$349B
$4.2M 0.91%
93,720
– –
SWK icon
33
Stanley Black & Decker
SWK
$13.9B
$4.16M 0.9%
29,571
-215
-0.7% -$29.5K
DOX icon
34
Amdocs
DOX
$5.63B
$3.96M 0.85%
61,369
-980
-2% -$61.9K
OUT icon
35
Outfront Media
OUT
$5.83B
$3.93M 0.85%
172,614
-789
-0.5% -$18.7K
BG icon
36
Bunge Global
BG
$22.9B
$3.79M 0.82%
50,806
-4,878
-9% -$371K
PX
37
DELISTED
Praxair Inc
PX
$3.79M 0.82%
28,579
+7,590
+36% +$973K
HOG icon
38
Harley-Davidson
HOG
$2.78B
$3.63M 0.78%
67,097
-532
-0.8% -$29.6K
EMR icon
39
Emerson Electric
EMR
$78B
$3.48M 0.75%
58,360
+9
+0% +$534
TTE icon
40
TotalEnergies
TTE
$180B
$3.44M 0.74%
69,265
+8,560
+14% +$440K
UL icon
41
Unilever
UL
$134B
$3.42M 0.74%
56,183
-12,362
-18% -$737K
LHX icon
42
L3Harris
LHX
$52.7B
$3.28M 0.71%
30,062
+12,014
+67% +$1.32M
RDS.A
43
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$3.26M 0.7%
61,313
-886
-1% -$47.4K
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.06T
$2.77M 0.6%
16,323
– –
AN icon
45
AutoNation
AN
$6.88B
$2.66M 0.57%
63,078
-7,148
-10% -$291K
BHI
46
DELISTED
Baker Hughes
BHI
$2.64M 0.57%
48,385
-68,016
-58% -$3.91M
MDLZ icon
47
Mondelez International
MDLZ
$78B
$2.39M 0.51%
55,256
– –
CCU icon
48
Compañía de Cervecerías Unidas
CCU
$2.07B
$2.05M 0.44%
78,111
+730
+0.9% +$19K
KT icon
49
KT
KT
$8.4B
$1.78M 0.38%
106,843
+970
+0.9% +$15.8K
VZ icon
50
Verizon
VZ
$182B
$1.66M 0.36%
37,269
-202,205
-84% -$9.42M
1
2
3

Similar funds

HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
WCM
WealthBridge Capital Management Westerville, Ohio $434M AUM 20.24% 1-Year Est. Return
CWA
Cornerstone Wealth Advisors Edina, Minnesota $434M AUM 11.97% 1-Year Est. Return
OPA
Old Port Advisors Portland, Maine $434M AUM 29.17% 1-Year Est. Return
PAMS
Pinpoint Asset Management (Singapore) Singapore $433M AUM 32.19% 1-Year Est. Return
SSWG
Seven Springs Wealth Group Brentwood, Tennessee $432M AUM 23% 1-Year Est. Return

Foyston, Gordon, & Payne's Q2 2017 Portfolio in Review

As of Q2 2017, Foyston, Gordon, & Payne held 69 positions worth $464M, up 0.05% from $464M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Foyston, Gordon, & Payne's Q2 2017 filing shows 32 increased, 23 reduced and 5 closed positions. The largest sale was Medtronic, an estimated $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

  • Foyston, Gordon, & Payne added most to Gentex in Q2 2017, an estimated $5.51M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2017 reduction was Medtronic, cutting an estimated $14.9M.
  • Foyston, Gordon, & Payne fully exited Syngenta Ag in Q2 2017, selling an estimated $2.5M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 47% of its $464M portfolio in Q2 2017.
  • Foyston, Gordon, & Payne opened 0 new positions and closed 5 in Q2 2017.
  • Foyston, Gordon, & Payne's portfolio value rose 0.05% quarter-over-quarter to $464M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2017, filed 14 Aug 2017.